| Dr Christopher M Lynch, MD | |
|
7440 Frontage Rd, Merriam, KS 66203-4670 | |
| (913) 236-6148 | |
| (913) 236-1111 |
| Full Name | Dr Christopher M Lynch |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 7440 Frontage Rd, Merriam, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992809164 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0426292 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Physician Services Llc | 1658500962 | 39 |
News Archive
The lifespan of a transplant kidney has significantly improved over the last thirty years. Between 1986 and 1995, 75% of the transplanted kidneys still functioned five years after the transplant. Between 2006 and 2015, this number had already risen to 84%.
Pulmonary hypertension (PH) is a rare, often incurable lung disorder that affects individuals of all ages, races and ethnic backgrounds. In the recent 4th World Conference on Pulmonary Hypertension held by the WHO, PH was classified into five groups based on its causes, highlighting both the magnitude of conditions associated with PH and how little we know of the etiology in many cases.
A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.
A good night's sleep is essential for a healthy body and mind, for when we sleep is when the body resets, repairs, and refreshes itself. A lot of people, however, have trouble falling or staying asleep, a condition known as insomnia that affects up to 30% of the population.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).
› Verified 7 days ago
| Entity Name | Midwest Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952734741 PECOS PAC ID: 1658500962 Enrollment ID: O20140207001686 |
News Archive
The lifespan of a transplant kidney has significantly improved over the last thirty years. Between 1986 and 1995, 75% of the transplanted kidneys still functioned five years after the transplant. Between 2006 and 2015, this number had already risen to 84%.
Pulmonary hypertension (PH) is a rare, often incurable lung disorder that affects individuals of all ages, races and ethnic backgrounds. In the recent 4th World Conference on Pulmonary Hypertension held by the WHO, PH was classified into five groups based on its causes, highlighting both the magnitude of conditions associated with PH and how little we know of the etiology in many cases.
A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.
A good night's sleep is essential for a healthy body and mind, for when we sleep is when the body resets, repairs, and refreshes itself. A lot of people, however, have trouble falling or staying asleep, a condition known as insomnia that affects up to 30% of the population.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher M Lynch, MD 7440 Frontage Rd, Merriam, KS 66203-4670 Ph: (913) 236-6148 | Dr Christopher M Lynch, MD 7440 Frontage Rd, Merriam, KS 66203-4670 Ph: (913) 236-6148 |
News Archive
The lifespan of a transplant kidney has significantly improved over the last thirty years. Between 1986 and 1995, 75% of the transplanted kidneys still functioned five years after the transplant. Between 2006 and 2015, this number had already risen to 84%.
Pulmonary hypertension (PH) is a rare, often incurable lung disorder that affects individuals of all ages, races and ethnic backgrounds. In the recent 4th World Conference on Pulmonary Hypertension held by the WHO, PH was classified into five groups based on its causes, highlighting both the magnitude of conditions associated with PH and how little we know of the etiology in many cases.
A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.
A good night's sleep is essential for a healthy body and mind, for when we sleep is when the body resets, repairs, and refreshes itself. A lot of people, however, have trouble falling or staying asleep, a condition known as insomnia that affects up to 30% of the population.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).
› Verified 7 days ago
Dr. Randy M Sheridan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7440 Frontage Rd, Merriam, KS 66203 Phone: 913-236-6148 Fax: 913-236-1111 | |
Dr. Melanie M Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7440 Frontage Rd, Merriam, KS 66203 Phone: 913-236-6455 Fax: 913-236-1111 | |
Dr. Ronald J Barnhart, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7440 Frontage Rd, Merriam, KS 66203 Phone: 913-236-6455 Fax: 913-236-1111 | |
Dr. Corinna A Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7440 Frontage Rd, Merriam, KS 66203 Phone: 913-236-6455 Fax: 913-236-1111 | |
Dr. Abigail Rose Proffer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7440 W. Frontage Road, Merriam, KS 66203 Phone: 913-236-6455 | |
Dr. Meghan Elizabeth Vaglio, M.D., M.P.H. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7440 W Frontage Rd, Merriam, KS 66203 Phone: 913-236-6455 | |
Dr. Sara Lange, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9301 W 74th St Ste 130, Merriam, KS 66204 Phone: 913-632-9130 Fax: 913-632-9149 |